Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21641868 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Condition: Breast Cancer
Interventions: Drug: tamoxifen;   Drug: anastrozole;   Drug: zoledronic acid

Indicates status has not been verified in more than two years